MEDILUXTRADING BR
Expert knowledge enabeling your objectives
The market of diagnostic imaging is primarily driven by the increasing demand for early disease diagnosis and widening scope of clinical applications, rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases, technological advancements in diagnostic imaging industry, and increasing investments, funds, and grants by public-private organizations.
The process of diagnosis uses data collection and complex analysis to determine a patient’s health and course of treatment. Accurate diagnosis is the most critical.
Our current leading equipment is the
BG-75 Biomarker Generator
Key features:
Less Space, Fewer People, User Friendly, Fully automated, Fully shielded, A More Cost-Effective Solution for hospitals which want to have their own on-site generator
CAPEX / OPEX
2
40-50 m
Personnel
Space
ABT Solution
Conventional
2
300-500 m
The full system
MLT seeks to fully support both prospective and committed customers throughout the entire lifecycle of the client relationship. It includes such as:
-
Early Stage Project Support
-
Supply Channel Development & Execution
-
Technical Support & Service
-
Device Regulatory Consultation
-
Site Readiness Planning
pns-mlt
mediluxtrading-BR
Key Information
Simple Integration
​
​
The BG-75 Biomarker Generator integrates a compact mini-cyclotron, kit based micro chemistry, and automated quality control, simplifying in-house production of [18F]
​
• FDG and advanced biomarkers.
• Push button graphic interface
• Kit based chemistry
• Single or batch dose production
• Final dose delivery to syringe or vial (option)
• Automated quality control testing
• Integrated cyclotron & chemistry self-shielding
• Complete production lab in a 30²m area
Economical Solution
​
The BG-75 Biomarker Generator provides a unique, affordable, and powerful alternative to conventional cyclotron solutions.
• 30 m area vs 300 m reduces build-out costs
• QC automation reduces specialist support
• 1-2 FTE vs. 4-5 FTE reduces operational costs
• Lower radiation minimizes regulatory burden